Skip to main content

Table 3 Select population characteristics

From: A meta-review of evidence on heart failure disease management programs: the challenges of describing and synthesizing evidence on complex interventions

Reporting of population characteristics   
No information on co-morbidities 7/15 [24, 25, 29, 30, 32, 33, 35]
Incomplete or no data on NYHA Classification 10/15 [9, 23, 24, 26, 27, 29, 30, 33, 3537]
No data on NYHA Classification 4/15 [23, 26, 27, 30]
Range of NYHA Classification only 6/15 [24, 25, 28, 31, 32, 37]
Information on LVEF 6/15 [25, 29, 31, 34, 36, 37]
Summaries of ACE-I and BB medication treatments 3/15 [32, 36, 37]
  1. aNYHA, New York Heart Association
  2. bLVEF, Left Ventricular Ejection Fraction
  3. cACE-I, Ace-Inhibitor
  4. dBB, Beta Blocker